Cargando…

Pretreatment (18) F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma——a retrospective study

BACKGROUND: Intratumoural heterogeneity has been demonstrated to be a strong indicator of malignant transformation. Our study was to investigate pretreatment (18) F-FDG parameters, including (18) F-FDG based heterogeneity for predicting survival in patients with locally advanced nasopharyngeal carci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Zhongyi, Shi, Qi, Zhang, Yongping, Pan, Herong, Yao, Zhifeng, Hu, Silong, Shi, Wei, Zhu, Beiling, Zhang, Yingjian, Hu, Chaosu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311496/ https://www.ncbi.nlm.nih.gov/pubmed/25566697 http://dx.doi.org/10.1186/s13014-014-0268-5

Ejemplares similares

(18)F-FLT and (18)F-FDG PET/CT in Predicting Response to Chemoradiotherapy in Nasopharyngeal Carcinoma: Preliminary Results
por: Qi, Shi, et al.
Publicado: (2017)

The Preliminary Study of 16α-[18F]fluoroestradiol PET/CT in Assisting the Individualized Treatment Decisions of Breast Cancer Patients
por: Sun, Yifei, et al.
Publicado: (2015)

Adding Maximum Standard Uptake Value of Primary Lesion and Lymph Nodes in (18)F-Fluorodeoxyglucose PET Helps Predict Distant Metastasis in Patients with Nasopharyngeal Carcinoma
por: Shi, Qi, et al.
Publicado: (2014)

Establishment and validation of a nomogram with intratumoral heterogeneity derived from (18)F-FDG PET/CT for predicting individual conditional risk of 5-year recurrence before initial treatment of nasopharyngeal carcinoma
por: Gu, Bingxin, et al.
Publicado: (2020)

Prediction of Pretreatment 18F-FDG-PET/CT Parameters on the Outcome of First-Line Therapy in Patients with Metastatic Breast Cancer
por: Li, Yi, et al.
Publicado: (2021)

Can Positron Emission Tomography/Computed Tomography with the Dual Tracers Fluorine-18 Fluoroestradiol and Fluorodeoxyglucose Predict Neoadjuvant Chemotherapy Response of Breast Cancer? ----A Pilot Study
por: Yang, Zhongyi, et al.
Publicado: (2013)

Pretreatment (18)F‐FDG uptake heterogeneity may predict treatment outcome of combined Trastuzumab and Pertuzumab therapy in patients with metastatic HER2 positive breast cancer
por: Ma, Guang, et al.
Publicado: (2023)

A preliminary study of (18)F-FES PET/CT in predicting metastatic breast cancer in patients receiving docetaxel or fulvestrant with docetaxel
por: Gong, Chengcheng, et al.
Publicado: (2017)

Prognostic value of pretreatment (18)F-FDG PET-CT for nasopharyngeal carcinoma patients
por: Huang, Yecai, et al.
Publicado: (2017)

Reflecting on the utility of standardized uptake values on (18)F-FDG PET in nasopharyngeal carcinoma
por: Qiu, Xiufang, et al.
Publicado: (2022)

Comparison of (18)F-FES, (18)F-FDG, and (18)F-FMISO PET Imaging Probes for Early Prediction and Monitoring of Response to Endocrine Therapy in a Mouse Xenograft Model of ER-Positive Breast Cancer
por: He, SiMin, et al.
Publicado: (2016)

Heterogeneous uptake of (18)F-FDG and (18)F-PSMA-1007 PET/CT in lung cancer and lymph node metastasis
por: Hu, Yuan, et al.
Publicado: (2023)

The preclinical study of predicting radiosensitivity in human nasopharyngeal carcinoma xenografts by 18F-ML-10 animal- PET/CT imaging
por: Bao, Xiao, et al.
Publicado: (2016)

The Efficacy of Pretreatment (18)F-FDG PET-CT-Based Deep Learning Network Structure to Predict Survival in Nasopharyngeal Carcinoma
por: Long, Zi-chan, et al.
Publicado: (2023)

Temporal Heterogeneity of HER2 Expression and Spatial Heterogeneity of (18)F-FDG Uptake Predicts Treatment Outcome of Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer
por: Gong, Chengcheng, et al.
Publicado: (2022)

(18)F-FDG Uptake Characteristics in Differentiating Benign from Malignant Nasopharyngeal Lesions in Children
por: Ma, Chao, et al.
Publicado: (2015)

The Added Value of (68)Ga-FAPI PET/CT in Patients with Head and Neck Cancer of Unknown Primary with (18)F-FDG–Negative Findings
por: Gu, Bingxin, et al.
Publicado: (2022)

The prognostic value of (18)F-FDG PET/CT intra-tumoural metabolic heterogeneity in pretreatment neuroblastoma patients
por: Liu, Jun, et al.
Publicado: (2022)

Prognostic Value of Heterogeneity Index Derived from Baseline (18)F-FDG PET/CT in Mantle Cell Lymphoma
por: Liu, Fei, et al.
Publicado: (2022)

PET-CT for Evaluation of Spleen and Liver (18)F-FDG Diffuse Uptake Without Lymph Node Enlargement in Lymphoma
por: Rao, Liangjun, et al.
Publicado: (2016)

The Role of Pretreatment (18)F-FDG PET/CT for Early Prediction of Neoadjuvant Chemotherapy Response in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
por: Yao, Jijin, et al.
Publicado: (2021)

Correlation of pretreatment (18)F-FDG uptake with clinicopathological factors and prognosis in patients with newly diagnosed diffuse large B-cell lymphoma
por: Huang, Honghui, et al.
Publicado: (2016)

Prognostic Value of Tumor Heterogeneity on 18F-FDG PET/CT in HR+HER2− Metastatic Breast Cancer Patients receiving 500 mg Fulvestrant: a retrospective study
por: Zhao, Yannan, et al.
Publicado: (2018)

Cancer-associated fibroblasts enhance tumor (18)F-FDG uptake and contribute to the intratumor heterogeneity of PET-CT
por: Shangguan, Chengfang, et al.
Publicado: (2018)

Dual Tracers of 16α-[18F]fluoro-17β-Estradiol and [18F]fluorodeoxyglucose for Prediction of Progression-Free Survival After Fulvestrant Therapy in Patients With HR+/HER2- Metastatic Breast Cancer
por: Liu, Cheng, et al.
Publicado: (2020)

[18F] FDG uptake: pay attention to candies
por: Travaini, LL, et al.
Publicado: (2007)

Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma
por: Yang, Shan-Shan, et al.
Publicado: (2021)

(18)F‐FDG uptake in denervated muscles of patients with peripheral nerve injury
por: Choi, Ji Soo, et al.
Publicado: (2019)

Pediatric Nasopharyngeal Carcinoma as Seen on 18F-FDG PET/CT
por: Muzaffar, Razi, et al.
Publicado: (2019)

Heterogeneity derived from (18)F‐FDG PET/CT predicts immunotherapy outcome for metastatic triple‐negative breast cancer patients
por: Xie, Yizhao, et al.
Publicado: (2022)

Comparison of Nasopharyngeal MR, (18) F-FDG PET/CT, and (18) F-FDG PET/MR for Local Detection of Natural Killer/T-Cell Lymphoma, Nasal Type
por: Guo, Rui, et al.
Publicado: (2020)

Gut microbiota and physiologic bowel (18)F-FDG uptake
por: Kang, Ji Yeon, et al.
Publicado: (2017)

Intrapatient variability of 18F-FDG uptake in normal tissues
por: Sayed, Mohamed Hosny Mohamed, et al.
Publicado: (2022)

Benign Colonic (18)F-FDG Uptake on Whole-Body FDG-PET Scan
por: Jang, Byung Ik
Publicado: (2012)

The preoperative SUVmax for (18)F-FDG uptake predicts survival in patients with colorectal cancer
por: Shi, Debing, et al.
Publicado: (2015)

Radiomics–clinical nomogram based on pretreatment 18F-FDG PET-CT radiomics features for individualized prediction of local failure in nasopharyngeal carcinoma
por: Ding, Jianming, et al.
Publicado: (2023)

Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative (18)F-FDG PET/CT analysis
por: de Heer, Ellen C., et al.
Publicado: (2018)

(18)F-FDG super bone marrow uptake: A highly potent indicator for the malignant infiltration
por: Alam, Mohammed Shah, et al.
Publicado: (2016)

Evaluation of tumour heterogeneity by (18)F-fluoroestradiol PET as a predictive measure in breast cancer patients receiving palbociclib combined with endocrine treatment
por: Liu, Cheng, et al.
Publicado: (2022)

Pituitary (18)F-FDG uptake correlates with serum TSH levels in thyroid cancer patients on (18)F-FDG PET/CT
por: Ding, Yingli, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r1lpeon664vatbn77g549c8f04